spacer
home > pmps > winter 2017 > inhalation education
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Inhalation Education

There are several advantages when using inhaled therapeutics, and they offer promising future growth in the respiratory market. According to the NIH, a nominal dose is ‘the total prescribed dose’ of an inhalable therapeutic. Commonly observed actual amounts (medicament effectively reaching the lung), however, range between 6 and 60% of the nominal measurement. Such incomplete prescriptions pose safety risks to patients and reduce the effectiveness of their treatments. The successful use of respiratory delivery devices depends on a number of considerations, including:
  • Properties of the lung
  • Disease state
  • Breathing patterns
  • Delivery techniques


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Joining the company just a few years after its creation, Craig Baker is Vice President at Noble. He holds an undergraduate degree from the University of Iowa, US, and a Master’s degree from the University of South Carolina, US. In addition, Craig has 10 years of management experience in the marketing industry and the pharmaceutical and healthcare field. This unique insight into both industries is an important advantage for the future growth of Noble.
spacer
Craig Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement